Article info

Download PDFPDF
Angiotensin-converting enzyme inhibitors versus receptor blockers: is one better than the other for cardiovascular prevention?

Authors

  1. Correspondence to Dr Yutaka Furukawa, Department of Cardiovascular Medicine, Kobe City Medical Center General Hospital, 2-1-1 Minatojima-minamimachi, Chuo-ku, Kobe 650-0047, Japan; furukawa{at}kcho.jp
View Full Text

Citation

Furukawa Y
Angiotensin-converting enzyme inhibitors versus receptor blockers: is one better than the other for cardiovascular prevention?

Publication history

  • First published April 4, 2017.
Online issue publication 
August 15, 2017

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.